Cd5 Cd19 PID (Health/Immune_Disorders)
scid.net
Description: Cd5 Cd19 PID, involves a complete and total lack of response to polysaccharide antibodies... and an extremely high expression of Cd5+ Bcells.In 1997, Dr. Robert W. Hostoffer DO, Director of Clinical Immunology at Clevelands Rainbow Babies and Childrens Hospital, made a remarkable break through in the discovery of an astonishing Primary Immune Deficiency. The syndrome, was given the name Cd5 Cd19 PID
Specializes in: immune deficiency primary immune deficiency polysaccharide antibody pneumococcal tcell bcell lymphocyte... lymphocytes

Rituxan Genentech (Health/Medications)
non-hodgkins-lymphoma.rituxan.com
Description: Information about NonHodgkins Lymphoma and Rituxan (Rituximab), the first U.S. approved... monoclonal antibody cancer treatment to treat NonHodgkins Lymphoma. Rituxan (Rituximab) is the first monoclonal antibody cancer therapy approved in the United States. Healthcare professionals can find clinical trial, dosage and administration, and patient reimbursement information (SPOC). Presented by Genentech, Inc, and Idec Pharmaceuticals, Inc
Specializes in: nonhodgkins lymphoma cancer treatment non hodgkins bcell rituxan... rituximab monoclonal